Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 712 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Mitochondrial Dysfunction Underlies Monocyte Immune Deficiency in Patients with Severe Alcohol-Related Hepatitis
Paul K. Middleton, Ricardo J. Aramayo, Alex Montoya, Pavel V. Shliaha, Simon Pope, Louise Fets,Nikhil Vergis,Mark R. Thursz, Helena M. Cochemé
biorxiv（2025）
Cited0Views0Bibtex
0
0
Pathological Expansion of Gut Microbiome-Associated Enterococcus in Advanced Cirrhosis Corresponds with Multilevel Perturbations of the Gut-Liver-immune Axis
Matthew J Dalby,Raymond Kiu,Marilena Stamouli, Betsy Arefaine,Lex EX Leong, Jack Hales, Christine Bernsmeier, Arjuna Singanayagam,Sidsel Stoy, Maria-Emanuela Maxan, Merianne Mohamad,Ane Zamalloa, Mark Lewis,Royce P Vincent,Roger Williams,Lindsey A Edwards, Shilpa Chokshi,Mark Thursz, Naiara Beraza,Charalambos G Antoniades, Geraint B Rogers, Julia A Wendon, Kenneth D Bruce,Debbie L Shawcross, Mark JW McPhail, Lindsay J Hall,Vishal C Patel
medrxiv（2025）
Cited0Views0Bibtex
0
0
P54 Β -Hydroxy Β-Methylbutyrate (HMB) Supplementation to Improve Functional Status in People with Advanced Liver Cirrhosis (BOOST): a Multicentre Double Blind Placebo-Controlled Randomised Trial Protocol
Ashwin Dhanda, Victoria Allgar,Philip Calder, Lynne Callghan, Mary Hickson, Lesley Manning, Paula Murphy,Mark Thursz
P54 β -hydroxy β-methylbutyrate (HMB) supplementation to improve functional status in people with advanced liver cirrhosis (BOOST) a multicentre double blind placebo-controlled randomised trial protocol (2024)
Cited0Views0Bibtex
0
0
Load More
Author Statistics

#Papers: 714

#Citation: 18430

H-Index: 73

G-Index: 123

Sociability: 8

Diversity: 3

Activity: 52

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn